NIJHAWAN PARDEEP (Chief Executive Officer) purchased 2.7% of their position (10K shares) of EDESA BIOTECH, INC. on the open market
Open‑market purchase worth $36.3K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/4/2026ACC: 0001171843-26-001329
DirectorOfficer10% Owner· Chief Executive Officer
Since Jun 2019
+10K
Net shares
Net buyer
$36.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Common Shares
Indirect
Shares
+10K
Price / share
$3.63
Trade value
$36.30K
% of position
2.7%
3/3/2026
372.70K→382.70K
Total
Net shares
+10K
Net value
$36.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Indirect | 3/3/2026 | P · Purchase | +10K | $3.63 | $36.30K | 2.7% | 372.70K | 382.70K |
| Total | +10K | $36.30K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Shares
DirectShares owned627.81K
Common Shares
IndirectShares owned32.61K
Common Shares
IndirectShares owned32.01K
Common Shares
IndirectShares owned53.10K
Total
627.81K direct·117.73K indirect745.54K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 627.81K | Direct |
| Common Shares | 32.61K | Indirect |
| Common Shares | 32.01K | Indirect |
| Common Shares | 53.10K | Indirect |
| Total | 745.54K | 627.81K direct·117.73K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported